UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM
8-K/A
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported)
April
24, 2009
Bovie
Medical Corporation
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
1-31885
|
11-2644611
|
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
|
Of
incorporation)
|
File
Number)
|
Identification
No.)
|
|
734
Walt Whitman Road, Melville, New York
|
11747
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code
(631)
421-5452
N/A
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act 17 CFR
230.425)
¨
Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17
CFR 240.l4a-12)
¨
Pre-commencement communications pursuant to Rule l4d- 2(b) under the Exchange
Act (17 CFR 240. l4d- 2(b)
¨
Pre-commencement communications pursuant to Rule 13 e-4( c) under the Exchange
Act (17 CFR 240.13 e-4( c)
|
ITEM:
5.02
|
Departure of Directors
or Certain Officers, Election of Directors, Appointment of Certain
Officers, Compensatory Arrangements of Certain
Officers.
|
(d)(1) On
April 23, 2009, at a special meeting duly called, the Board of Directors of
Bovie Medical Corporation elected Peter Pardoll as an independent
director.
(d)(2)
Since July, 2003, Mr. Pardoll has served and continues to serve as a medical
consultant to our Company with respect to Company projects. Such
consulting relationship has not been affected or changed in any way by virtue of
this election to the Board.
|
ITEM:
5.03
|
Amendment to Articles
of Incorporation or By-Laws, Changes in Fiscal
Year
|
|
|
(a)
|
On
April 23, 2009, pursuant to special meeting of the Board of Directors, the
first sentence of Article III, Section (a) of the By-Laws of the
Corporation was amended to increase the maximum of directors of the
corporation from seven (7) to nine
(9).
|
First sentence of Article
III, Section (a) formerly read as follows:
“the
number of Directors of the Corporation shall be no more than seven (7) unless
and until otherwise determined by vote of a majority of the entire Board of
Directors…..”
The new first sentence of
Article III Section (a), reads as follows:
“the
number of directors of the corporation shall be no more than nine (9) unless and
until otherwise determined by vote of a majority of the entire Board of
Directors….”
Signatures
Pursuant
to the requirements of Securities Exchange Act of 1934 the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
Date: October
8, 2009
|
Bovie
Medical Corp
|
|
(Registrant)
|
|
|
By:
/S/Andrew
Makrides
|
|
|
Andrew
Makrides, President and CEO
|